Buckland Partners Management Co LLC bought a new stake in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 11,000 shares of the company's stock, valued at approximately $5,313,000. Astera Labs accounts for about 2.6% of Buckland Partners Management Co LLC's investment portfolio, making the stock its 6th biggest holding.
A number of other institutional investors have also recently bought and sold shares of the stock. Eurizon Capital SGR S.p.A. purchased a new stake in Astera Labs during the fourth quarter worth approximately $18,708,000. Swedbank AB raised its stake in shares of Astera Labs by 76.8% in the 4th quarter. Swedbank AB now owns 78,140 shares of the company's stock valued at $12,999,000 after acquiring an additional 33,940 shares during the period. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. purchased a new position in shares of Astera Labs in the 4th quarter valued at $499,000. Revere Asset Management Inc acquired a new position in shares of Astera Labs during the 4th quarter valued at $589,000. Finally, Banque Cantonale Vaudoise lifted its holdings in shares of Astera Labs by 85.9% during the 1st quarter. Banque Cantonale Vaudoise now owns 6,990 shares of the company's stock valued at $766,000 after acquiring an additional 3,229 shares in the last quarter. 60.47% of the stock is currently owned by hedge funds and other institutional investors.
Astera Labs Price Performance
Shares of ALAB stock opened at $320.17 on Tuesday. Astera Labs, Inc. has a 12 month low of $97.89 and a 12 month high of $499.48. The firm has a market capitalization of $55.55 billion, a P/E ratio of 158.50 and a beta of 3.84. The company's fifty day moving average price is $357.48 and its two-hundred day moving average price is $241.79.
Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating analysts' consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company had revenue of $392.40 million during the quarter, compared to analysts' expectations of $360.85 million. During the same period in the prior year, the company posted $0.44 EPS. The firm's revenue for the quarter was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, sell-side analysts anticipate that Astera Labs, Inc. will post 2.7 EPS for the current year.
Wall Street Analysts Forecast Growth
ALAB has been the subject of several recent research reports. JPMorgan Chase & Co. increased their price target on Astera Labs from $205.00 to $280.00 and gave the company an "overweight" rating in a report on Wednesday, May 6th. Jefferies Financial Group boosted their price objective on Astera Labs from $270.00 to $450.00 and gave the stock a "buy" rating in a research note on Wednesday, August 5th. Zacks Research raised Astera Labs from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, August 11th. Stifel Nicolaus increased their target price on Astera Labs from $260.00 to $460.00 and gave the company a "buy" rating in a research note on Wednesday, June 24th. Finally, TD Cowen dropped their target price on Astera Labs from $425.00 to $375.00 and set a "hold" rating on the stock in a report on Wednesday, August 5th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $333.00.
Check Out Our Latest Stock Report on Astera Labs
Insiders Place Their Bets
In other Astera Labs news, COO Sanjay Gajendra sold 400,000 shares of the company's stock in a transaction that occurred on Thursday, May 21st. The stock was sold at an average price of $290.30, for a total value of $116,120,000.00. Following the transaction, the chief operating officer directly owned 5,064,213 shares of the company's stock, valued at $1,470,141,033.90. This represents a 7.32% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 8,994 shares of the stock in a transaction that occurred on Wednesday, June 3rd. The shares were sold at an average price of $364.35, for a total value of $3,276,963.90. Following the transaction, the director owned 5,292 shares of the company's stock, valued at approximately $1,928,140.20. This trade represents a 62.96% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 631,979 shares of company stock worth $215,479,247. Company insiders own 10.40% of the company's stock.
Astera Labs Profile
(
Free Report)
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Astera Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.
While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.